Umiya Buildcon Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 6, 2025, 6:52 am

Quick Insight

MRO-TEK Realty Ltd's current market price of 61.2 reflects a P/E ratio of 39.8, indicating a relatively high valuation compared to its industry peers. With a ROE of 5.34% and ROCE of 7.72%, the company's profitability metrics suggest room for improvement. The OPM stands at a healthy 45.07%, showcasing operational efficiency. However, the company's net profit of 3.60 Cr. may raise concerns about its bottom line performance. Additionally, with borrowings amounting to ₹125.97 Cr. and a P/BV of 1.92x, the company's leverage and valuation multiples warrant close monitoring. In conclusion, investors should closely track MRO-TEK's efforts to enhance profitability and manage its debt levels to ensure sustainable growth.

Competitors of Umiya Buildcon Ltd

All Competitor Stocks of Umiya Buildcon Ltd

Quarterly Result

Last Updated: September 5, 2025, 10:14 am

Below is a detailed analysis of the quarterly data for Umiya Buildcon Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
• For Expenses, as of Jun 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
• For OPM %, as of Jun 2025, the value is 31.00%. The value appears strong and on an upward trend. It has increased from 26.00% (Mar 2025) to 31.00%, marking an increase of 5.00%.
• For Other Income, as of Jun 2025, the value is 38.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 38.00 Cr., marking an increase of 37.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 39.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 39.00 Cr., marking an increase of 38.00 Cr..
• For Tax %, as of Jun 2025, the value is 18.00%. The value appears to be improving (decreasing) as expected. It has decreased from 48.00% (Mar 2025) to 18.00%, marking a decrease of 30.00%.
• For Net Profit, as of Jun 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2025) to 31.00 Cr., marking an increase of 31.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 16.82. The value appears strong and on an upward trend. It has increased from 0.18 (Mar 2025) to 16.82, marking an increase of 16.64.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: September 5, 2025, 10:14 am

Balance Sheet

Last Updated: September 5, 2025, 10:14 am

Below is a detailed analysis of the balance sheet data for Umiya Buildcon Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.00 Cr..
• For Reserves, as of Mar 2025, the value is 66.00 Cr.. The value appears strong and on an upward trend. It has increased from 60.00 Cr. (Mar 2024) to 66.00 Cr., marking an increase of 6.00 Cr..
• For Borrowings, as of Mar 2025, the value is 129.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 117.00 Cr. (Mar 2024) to 129.00 Cr., marking an increase of 12.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 44.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Mar 2024) to 44.00 Cr., marking an increase of 26.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 248.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 204.00 Cr. (Mar 2024) to 248.00 Cr., marking an increase of 44.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 121.00 Cr.. The value appears to be declining and may need further review. It has decreased from 122.00 Cr. (Mar 2024) to 121.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 127.00 Cr.. The value appears strong and on an upward trend. It has increased from 82.00 Cr. (Mar 2024) to 127.00 Cr., marking an increase of 45.00 Cr..
• For Total Assets, as of Mar 2025, the value is 248.00 Cr.. The value appears strong and on an upward trend. It has increased from 204.00 Cr. (Mar 2024) to 248.00 Cr., marking an increase of 44.00 Cr..

However, the Borrowings (129.00 Cr.) are higher than the Reserves (66.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Umiya Buildcon Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.13. This value is below the healthy minimum of 5. It has increased from 1.78 (Mar 24) to 3.13, marking an increase of 1.35.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.13. This value is below the healthy minimum of 5. It has increased from 1.78 (Mar 24) to 3.13, marking an increase of 1.35.
• For Cash EPS (Rs.), as of Mar 25, the value is 4.79. This value is within the healthy range. It has increased from 3.09 (Mar 24) to 4.79, marking an increase of 1.70.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 40.10. It has increased from 37.01 (Mar 24) to 40.10, marking an increase of 3.09.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 40.10. It has increased from 37.01 (Mar 24) to 40.10, marking an increase of 3.09.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 26.01. It has increased from 18.80 (Mar 24) to 26.01, marking an increase of 7.21.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 11.62. This value is within the healthy range. It has increased from 7.83 (Mar 24) to 11.62, marking an increase of 3.79.
• For PBIT / Share (Rs.), as of Mar 25, the value is 9.96. This value is within the healthy range. It has increased from 6.52 (Mar 24) to 9.96, marking an increase of 3.44.
• For PBT / Share (Rs.), as of Mar 25, the value is 4.01. This value is within the healthy range. It has increased from 1.75 (Mar 24) to 4.01, marking an increase of 2.26.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 3.13. This value is within the healthy range. It has increased from 1.78 (Mar 24) to 3.13, marking an increase of 1.35.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.13. This value is within the healthy range. It has increased from 1.78 (Mar 24) to 3.13, marking an increase of 1.35.
• For PBDIT Margin (%), as of Mar 25, the value is 44.65. This value is within the healthy range. It has increased from 41.64 (Mar 24) to 44.65, marking an increase of 3.01.
• For PBIT Margin (%), as of Mar 25, the value is 38.26. This value exceeds the healthy maximum of 20. It has increased from 34.68 (Mar 24) to 38.26, marking an increase of 3.58.
• For PBT Margin (%), as of Mar 25, the value is 15.42. This value is within the healthy range. It has increased from 9.31 (Mar 24) to 15.42, marking an increase of 6.11.
• For Net Profit Margin (%), as of Mar 25, the value is 12.01. This value exceeds the healthy maximum of 10. It has increased from 9.44 (Mar 24) to 12.01, marking an increase of 2.57.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.01. This value is within the healthy range. It has increased from 9.44 (Mar 24) to 12.01, marking an increase of 2.57.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.79. This value is below the healthy minimum of 15. It has increased from 4.79 (Mar 24) to 7.79, marking an increase of 3.00.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.90. This value is below the healthy minimum of 10. It has increased from 6.44 (Mar 24) to 8.90, marking an increase of 2.46.
• For Return On Assets (%), as of Mar 25, the value is 2.35. This value is below the healthy minimum of 5. It has increased from 1.63 (Mar 24) to 2.35, marking an increase of 0.72.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.51. This value exceeds the healthy maximum of 1. It has decreased from 1.56 (Mar 24) to 1.51, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.70. This value exceeds the healthy maximum of 1. It has increased from 1.69 (Mar 24) to 1.70, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.21. It has increased from 0.19 (Mar 24) to 0.21, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has decreased from 4.27 (Mar 24) to 1.59, marking a decrease of 2.68.
• For Quick Ratio (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 3.86 (Mar 24) to 1.15, marking a decrease of 2.71.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 4. It has decreased from 1.97 (Mar 24) to 1.01, marking a decrease of 0.96.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.95. This value is below the healthy minimum of 3. It has increased from 1.64 (Mar 24) to 1.95, marking an increase of 0.31.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.53. This value is below the healthy minimum of 3. It has increased from 1.37 (Mar 24) to 1.53, marking an increase of 0.16.
• For Enterprise Value (Cr.), as of Mar 25, the value is 227.60. It has increased from 214.87 (Mar 24) to 227.60, marking an increase of 12.73.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.68. This value exceeds the healthy maximum of 3. It has decreased from 6.12 (Mar 24) to 4.68, marking a decrease of 1.44.
• For EV / EBITDA (X), as of Mar 25, the value is 10.49. This value is within the healthy range. It has decreased from 14.68 (Mar 24) to 10.49, marking a decrease of 4.19.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.20. This value is within the healthy range. It has decreased from 3.79 (Mar 24) to 2.20, marking a decrease of 1.59.
• For Price / BV (X), as of Mar 25, the value is 1.43. This value is within the healthy range. It has decreased from 1.92 (Mar 24) to 1.43, marking a decrease of 0.49.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.20. This value is within the healthy range. It has decreased from 3.79 (Mar 24) to 2.20, marking a decrease of 1.59.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.05, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness